Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Molloy, SF"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-12 z 12
    Tytuł:
    Implementation of WHO guidelines on management of advanced HIV disease and its impact among TB co-infected patients in Tanzania: a retrospective follow-up study.
    Autorzy:
    Hassan FE; National Institute for Medical Research- Muhimbili Research Centre, Dar es Salaam, Tanzania. .
    Senkoro M; National Institute for Medical Research- Muhimbili Research Centre, Dar es Salaam, Tanzania.
    Mnyambwa NP; National Institute for Medical Research- Muhimbili Research Centre, Dar es Salaam, Tanzania.
    Wilfred A; National Institute for Medical Research- Muhimbili Research Centre, Dar es Salaam, Tanzania.
    Molloy SF; Institute for Infection and Immunity, St George's University of London, London, UK.
    Manisha H; National Institute for Medical Research- Muhimbili Research Centre, Dar es Salaam, Tanzania.
    Kivuyo S; National Institute for Medical Research- Muhimbili Research Centre, Dar es Salaam, Tanzania.
    Mfinanga SG; National Institute for Medical Research- Muhimbili Research Centre, Dar es Salaam, Tanzania.
    Pokaż więcej
    Źródło:
    BMC public health [BMC Public Health] 2022 May 27; Vol. 22 (1), pp. 1058. Date of Electronic Publication: 2022 May 27.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Coinfection*
    HIV Infections*/complications
    HIV Infections*/diagnosis
    HIV Infections*/drug therapy
    Tuberculosis*/complications
    Tuberculosis*/diagnosis
    Tuberculosis*/drug therapy
    Female ; Follow-Up Studies ; Humans ; Male ; Retrospective Studies ; Tanzania/epidemiology ; World Health Organization
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Combination Therapy for HIV-Associated Cryptococcal Meningitis-A Success Story.
    Autorzy:
    Hurt WJ; Institute of Infection & Immunity, St George's University London, London SW17 0RE, UK.
    Harrison TS; Institute of Infection & Immunity, St George's University London, London SW17 0RE, UK.; Clinical Academic Group in Infection & Immunity, St George's University Hospitals NHS Trust, London SW17 0QT, UK.; The MRC Centre of Medical Mycology, University of Exeter, Stocker Road, Exeter EX4 4QD, UK.
    Molloy SF; Institute of Infection & Immunity, St George's University London, London SW17 0RE, UK.
    Bicanic TA; Institute of Infection & Immunity, St George's University London, London SW17 0RE, UK.; Clinical Academic Group in Infection & Immunity, St George's University Hospitals NHS Trust, London SW17 0QT, UK.; The MRC Centre of Medical Mycology, University of Exeter, Stocker Road, Exeter EX4 4QD, UK.
    Pokaż więcej
    Źródło:
    Journal of fungi (Basel, Switzerland) [J Fungi (Basel)] 2021 Dec 20; Vol. 7 (12). Date of Electronic Publication: 2021 Dec 20.
    Typ publikacji:
    Journal Article; Review
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Short-term Mortality Outcomes of HIV-Associated Cryptococcal Meningitis in Antiretroviral Therapy-Naïve and -Experienced Patients in Sub-Saharan Africa.
    Autorzy:
    Kalata N; Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
    Ellis J; Division of Infection and Immunity, University College London, London, UK.
    Kanyama C; University of North Carolina Project, Kamuzu Central Hospital, Lilongwe, Malawi.
    Kuoanfank C; University of Dschang, Dschang, Cameroon.
    Temfack E; Douala General Hospital, Douala, Cameroon.
    Mfinanga S; Muhimbili Centre, National Institute for Medical Research, Dar Es Salaam, Tanzania.
    Lesikari S; Muhimbili Centre, National Institute for Medical Research, Dar Es Salaam, Tanzania.
    Chanda D; University Teaching Hospital, Lusaka, Zambia.
    Lakhi S; University Teaching Hospital, Lusaka, Zambia.
    Nyazika T; Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
    Chan AK; Dignitas International, Zomba Central Hospital, Zomba, Malawi.; Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
    van Oosterhout JJ; Dignitas International, Zomba Central Hospital, Zomba, Malawi.
    Chen T; Liverpool School of Tropical Medicine, Liverpool, UK.
    Hosseinipour MC; University of North Carolina Project, Kamuzu Central Hospital, Lilongwe, Malawi.
    Lortholary O; Necker Pasteur Center for Infectious Diseases and Tropical Medicine, IHU Imagine, Assistance Publique-Hôpitaux de Paris, Paris, France.
    Wang D; Liverpool School of Tropical Medicine, Liverpool, UK.
    Jaffar S; Liverpool School of Tropical Medicine, Liverpool, UK.
    Loyse A; Centre for Global Health, Institute of Infection and Immunity, St George University of London, London, UK.
    Heyderman RS; Division of Infection and Immunity, University College London, London, UK.
    Harrison TS; Centre for Global Health, Institute of Infection and Immunity, St George University of London, London, UK.; MRC Centre for Medical Mycology, University of Exeter, Exeter, UK.
    Molloy SF; Centre for Global Health, Institute of Infection and Immunity, St George University of London, London, UK.
    Pokaż więcej
    Źródło:
    Open forum infectious diseases [Open Forum Infect Dis] 2021 Jul 28; Vol. 8 (10), pp. ofab397. Date of Electronic Publication: 2021 Jul 28 (Print Publication: 2021).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Fungal Burden and Raised Intracranial Pressure Are Independently Associated With Visual Loss in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis.
    Autorzy:
    Molloy SF; Centre for Global Health, Institute of Infection and Immunity, St George's University of London, London, United Kingdom.; Clinical Academic Group in Infection, St George's University Hospital, LondonUnited Kingdom.
    Ross B; Centre for Global Health, Institute of Infection and Immunity, St George's University of London, London, United Kingdom.
    Kanyama C; UNC Project, Kamuzu Central Hospital, Lilongwe, Malawi.
    Mfinanga S; National Institute for Medical Research, Muhimbili Centre, Dar es Salaam, Tanzania.; Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
    Lesikari S; National Institute for Medical Research, Muhimbili Centre, Dar es Salaam, Tanzania.
    Heyderman RS; University College London, London, United Kingdom.; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.; College of Medicine, Queen Elizabeth Hospital, Blantyre, Malawi.
    Kalata N; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.; College of Medicine, Queen Elizabeth Hospital, Blantyre, Malawi.
    Ellis J; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.; College of Medicine, Queen Elizabeth Hospital, Blantyre, Malawi.; The Hospital for Tropical Diseases, University College Hospital, LondonUnited Kingdom.
    Kouanfack C; Hȏpital Central Yaoundé/Site ANRS Cameroun, Yaoundé, Cameroon.
    Chanda D; Institute for Medical Research and Training, University Teaching Hospital, Lusaka, Zambia.
    Temfack E; Douala General Hospital, Douala, Cameroon.; National Public Health Laboratory, Yaounde, Cameroon.
    Lakhi S; University Teaching Hospital, Lusaka, Zambia.
    Moodley A; Department of Neurology, University of the Free State, Bloemfontein, South Africa.
    Chan AK; Dignitas International, Zomba Central Hospital, Zomba, Malawi.; Division of Infectious Diseases, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
    van Oosterhout JJ; Partners in Hope, LilongweMalawi.; David Geffen School of Medicine, University of California, Los Angeles, USA.
    Mapoure Y; Douala General Hospital, Douala, Cameroon.
    Mwaba P; Department of Internal Medicine and Directorate of Research and Post Graduate Studies, Lusaka Apex Medical University, Lusaka, Zambia.
    Lalloo DG; Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
    Wang D; Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
    Lortholary O; Institut Pasteur, Molecular Mycology Unit, Centre National de la Recherche Scientifique, Paris, France.; Paris Descartes University, Necker Pasteur Center for Infectious Diseases and Tropical Medicine, Institut Imagine, Assistance Publique - Hôpitaux de Paris, Paris, France.
    Jaffar S; Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
    Hosseinipour MC; UNC Project, Kamuzu Central Hospital, Lilongwe, Malawi.; University of North Carolina, Chapel Hill, North Carolina, USA.
    Loyse A; Centre for Global Health, Institute of Infection and Immunity, St George's University of London, London, United Kingdom.; Clinical Academic Group in Infection, St George's University Hospital, LondonUnited Kingdom.
    Harrison TS; Centre for Global Health, Institute of Infection and Immunity, St George's University of London, London, United Kingdom.; Clinical Academic Group in Infection, St George's University Hospital, LondonUnited Kingdom.
    Bicanic T; Centre for Global Health, Institute of Infection and Immunity, St George's University of London, London, United Kingdom.; Clinical Academic Group in Infection, St George's University Hospital, LondonUnited Kingdom.
    Pokaż więcej
    Źródło:
    Open forum infectious diseases [Open Forum Infect Dis] 2021 Feb 05; Vol. 8 (4), pp. ofab066. Date of Electronic Publication: 2021 Feb 05 (Print Publication: 2021).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.
    Autorzy:
    Lawrence DS; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK. .; Botswana-Harvard AIDS Institute Partnership, Gaborone, Botswana. .
    Youssouf N; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.; Botswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
    Molloy SF; Research Centre for Infection and Immunity, St George's University of London, London, UK.
    Alanio A; Molecular Mycology Unit and National Reference Centre for Invasive Mycoses, Institut Pasteur, Paris, France.
    Alufandika M; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi.
    Boulware DR; Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.; Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
    Boyer-Chammard T; Molecular Mycology Unit and National Reference Centre for Invasive Mycoses, Institut Pasteur, Paris, France.
    Chen T; Department of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.
    Dromer F; Molecular Mycology Unit and National Reference Centre for Invasive Mycoses, Institut Pasteur, Paris, France.
    Hlupeni A; Department of Medicine, University of Zimbabwe College of Health Sciences, Parirenyatwa Hospital, Harare, Zimbabwe.
    Hope W; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
    Hosseinipour MC; Lilongwe Medical Relief Trust (UNC Project), Lilongwe, Malawi.
    Kanyama C; Lilongwe Medical Relief Trust (UNC Project), Lilongwe, Malawi.
    Lortholary O; Molecular Mycology Unit and National Reference Centre for Invasive Mycoses, Institut Pasteur, Paris, France.
    Loyse A; Research Centre for Infection and Immunity, St George's University of London, London, UK.
    Meya DB; Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
    Mosepele M; Botswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.; Department of Internal Medicine, University of Botswana, Gaborone, Botswana.
    Muzoora C; Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
    Mwandumba HC; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi.; Department of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.
    Ndhlovu CE; Department of Medicine, University of Zimbabwe College of Health Sciences, Parirenyatwa Hospital, Harare, Zimbabwe.
    Niessen L; Department of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.
    Schutz C; Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine, and Department of Medicine, University of Cape Town, Cape Town, South Africa.
    Stott KE; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi.; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
    Wang D; Department of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.
    Lalloo DG; Department of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.
    Meintjes G; Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine, and Department of Medicine, University of Cape Town, Cape Town, South Africa.
    Jaffar S; Department of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.
    Harrison TS; Research Centre for Infection and Immunity, St George's University of London, London, UK.
    Jarvis JN; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.; Botswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
    Pokaż więcej
    Źródło:
    Trials [Trials] 2019 Jan 14; Vol. 20 (1), pp. 48. Date of Electronic Publication: 2019 Jan 14.
    Typ publikacji:
    Journal Article; Published Erratum
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.
    Autorzy:
    Lawrence DS; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK. .; Botswana-Harvard AIDS Institute Partnership, Gaborone, Botswana. .
    Youssouf N; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.; Botswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
    Molloy SF; Research Centre for Infection and Immunity, St George's University of London, London, UK.
    Alanio A; Molecular Mycology Unit and National Reference Centre for Invasive Mycoses, Institut Pasteur, Paris, France.
    Alufandika M; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi.
    Boulware DR; Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.; Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
    Boyer-Chammard T; Molecular Mycology Unit and National Reference Centre for Invasive Mycoses, Institut Pasteur, Paris, France.
    Chen T; Department of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.
    Dromer F; Molecular Mycology Unit and National Reference Centre for Invasive Mycoses, Institut Pasteur, Paris, France.
    Hlupeni A; Department of Medicine, University of Zimbabwe College of Health Sciences, Parirenyatwa Hospital, Harare, Zimbabwe.
    Hope W; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
    Hosseinipour MC; Lilongwe Medical Relief Trust (UNC Project), Lilongwe, Malawi.
    Kanyama C; Lilongwe Medical Relief Trust (UNC Project), Lilongwe, Malawi.
    Lortholary O; Molecular Mycology Unit and National Reference Centre for Invasive Mycoses, Institut Pasteur, Paris, France.
    Loyse A; Research Centre for Infection and Immunity, St George's University of London, London, UK.
    Meya DB; Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
    Mosepele M; Botswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.; Department of Internal Medicine, University of Botswana, Gaborone, Botswana.
    Muzoora C; Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
    Mwandumba HC; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi.; Department of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.
    Ndhlovu CE; Department of Medicine, University of Zimbabwe College of Health Sciences, Parirenyatwa Hospital, Harare, Zimbabwe.
    Niessen L; Department of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.
    Schutz C; Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine, and Department of Medicine, University of Cape Town, Cape Town, South Africa.
    Stott KE; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi.; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
    Wang D; Department of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.
    Lalloo DG; Department of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.
    Meintjes G; Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine, and Department of Medicine, University of Cape Town, Cape Town, South Africa.
    Jaffar S; Department of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.
    Harrison TS; Research Centre for Infection and Immunity, St George's University of London, London, UK.
    Jarvis JN; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.; Botswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
    Pokaż więcej
    Źródło:
    Trials [Trials] 2018 Nov 23; Vol. 19 (1), pp. 649. Date of Electronic Publication: 2018 Nov 23.
    Typ publikacji:
    Clinical Trial Protocol; Journal Article
    MeSH Terms:
    Amphotericin B/*administration & dosage
    Antifungal Agents/*administration & dosage
    Cryptococcus neoformans/*drug effects
    Meningitis, Cryptococcal/*drug therapy
    Africa South of the Sahara ; Amphotericin B/adverse effects ; Amphotericin B/economics ; Amphotericin B/pharmacokinetics ; Antifungal Agents/adverse effects ; Antifungal Agents/economics ; Antifungal Agents/pharmacokinetics ; Clinical Trials, Phase III as Topic ; Cost-Benefit Analysis ; Cryptococcus neoformans/pathogenicity ; Drug Administration Schedule ; Drug Costs ; Drug Therapy, Combination ; Equivalence Trials as Topic ; Fluconazole/administration & dosage ; Flucytosine/administration & dosage ; Humans ; Induction Chemotherapy ; Meningitis, Cryptococcal/economics ; Meningitis, Cryptococcal/microbiology ; Meningitis, Cryptococcal/mortality ; Multicenter Studies as Topic ; Time Factors ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Cryptococcal meningitis: A neglected NTD?
    Autorzy:
    Molloy SF; Centre for Global Health, Institute for Infection and Immunity, St George's, University of London, London, United Kingdom.
    Chiller T; Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
    Greene GS; Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
    Burry J; Medecins Sans Frontières Access Campaign, Médecins Sans Frontières, Geneva, Switzerland.
    Govender NP; National Institute for Communicable Diseases (Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses), Johannesburg, South Africa.; Division of Medical Microbiology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
    Kanyama C; University of North Carolina Project, Lilongwe, Malawi.
    Mfinanga S; National Institute of Medial Research, Muhimbili Medical Research Centre, Dar Es Salaam, Tanzania.
    Lesikari S; National Institute of Medial Research, Muhimbili Medical Research Centre, Dar Es Salaam, Tanzania.
    Mapoure YN; Central Hospital, Yaoundé, Cameroon.
    Kouanfack C; Department of Internal Medicine, Douala General Hospital, Douala, Cameroon.
    Sini V; Department of Internal Medicine, Douala General Hospital, Douala, Cameroon.
    Temfack E; Central Hospital, Yaoundé, Cameroon.
    Boulware DR; Division of Infectious Disease and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, United States of America.
    Dromer F; Institut Pasteur, Molecular Mycology-CNRS URA3012, Department of Mycology, Paris, France.
    Denning DW; Global Action Fund for Fungal Infections (GAFFI), Geneva, Switzerland.
    Day J; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme Vietnam, Ho Chi Minh City, Vietnam.; Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
    Stone NRH; Centre for Global Health, Institute for Infection and Immunity, St George's, University of London, London, United Kingdom.
    Bicanic T; Centre for Global Health, Institute for Infection and Immunity, St George's, University of London, London, United Kingdom.
    Jarvis JN; Department of Clinical Research, Faculty of Infectious & Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Botswana-University of Pennsylvania Partnership, Gaborone, Botswana.; Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
    Lortholary O; Institut Pasteur, Molecular Mycology-CNRS URA3012, Department of Mycology, Paris, France.
    Harrison TS; Centre for Global Health, Institute for Infection and Immunity, St George's, University of London, London, United Kingdom.
    Jaffar S; Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
    Loyse A; Centre for Global Health, Institute for Infection and Immunity, St George's, University of London, London, United Kingdom.
    Pokaż więcej
    Źródło:
    PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2017 Jun 29; Vol. 11 (6), pp. e0005575. Date of Electronic Publication: 2017 Jun 29 (Print Publication: 2017).
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Neglected Diseases*
    Tropical Medicine*
    Meningitis, Cryptococcal/*prevention & control
    Antifungal Agents/therapeutic use ; Biomedical Research ; Global Health ; Humans ; Meningitis, Cryptococcal/epidemiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Plasma cytokines, chemokines and cellular immune responses in pre-school Nigerian children infected with Plasmodium falciparum.
    Autorzy:
    Noone C; Parasite Immune Modulation Group, School of Nursing and Human Sciences, Faculty of Science and Health, Dublin City University, Glasnevin Dublin 9, Ireland.
    Parkinson M
    Dowling DJ
    Aldridge A
    Kirwan P
    Molloy SF
    Asaolu SO
    Holland C
    O'Neill SM
    Pokaż więcej
    Źródło:
    Malaria journal [Malar J] 2013 Jan 07; Vol. 12, pp. 5. Date of Electronic Publication: 2013 Jan 07.
    Typ publikacji:
    Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Immunity, Cellular*
    Cytokines/*blood
    Leukocytes, Mononuclear/*immunology
    Malaria, Falciparum/*immunology
    Plasma/*chemistry
    Plasmodium falciparum/*immunology
    Child ; Child, Preschool ; Humans ; Immunophenotyping ; Nigeria ; T-Lymphocyte Subsets/immunology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Ascaris co-infection does not alter malaria-induced anaemia in a cohort of Nigerian preschool children.
    Autorzy:
    Abanyie FA; Emory University School of Medicine, Atlanta, GA 30322, USA.
    McCracken C
    Kirwan P
    Molloy SF
    Asaolu SO
    Holland CV
    Gutman J
    Lamb TJ
    Pokaż więcej
    Źródło:
    Malaria journal [Malar J] 2013 Jan 02; Vol. 12, pp. 1. Date of Electronic Publication: 2013 Jan 02.
    Typ publikacji:
    Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Anemia/*pathology
    Ascariasis/*complications
    Coinfection/*complications
    Malaria/*complications
    Anemia/etiology ; Animals ; Anthelmintics/administration & dosage ; Ascariasis/drug therapy ; Ascariasis/parasitology ; Ascariasis/pathology ; Ascaris lumbricoides/pathogenicity ; Child, Preschool ; Coinfection/pathology ; Humans ; Infant ; Malaria/pathology ; Nigeria
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Impact of repeated four-monthly anthelmintic treatment on Plasmodium infection in preschool children: a double-blind placebo-controlled randomized trial.
    Autorzy:
    Kirwan P; Department of Zoology, University of Dublin, Trinity College, Dublin 2, Ireland. />Jackson AL
    Asaolu SO
    Molloy SF
    Abiona TC
    Bruce MC
    Ranford-Cartwright L
    O' Neill SM
    Holland CV
    Pokaż więcej
    Źródło:
    BMC infectious diseases [BMC Infect Dis] 2010 Sep 21; Vol. 10, pp. 277. Date of Electronic Publication: 2010 Sep 21.
    Typ publikacji:
    Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Albendazole/*administration & dosage
    Anthelmintics/*administration & dosage
    Malaria/*drug therapy
    Animals ; Ascariasis/drug therapy ; Ascaris lumbricoides/drug effects ; Ascaris lumbricoides/isolation & purification ; Child, Preschool ; Double-Blind Method ; Female ; Humans ; Infant ; Male ; Placebos/administration & dosage ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Patterns of soil-transmitted helminth infection and impact of four-monthly albendazole treatments in preschool children from semi-urban communities in Nigeria: a double-blind placebo-controlled randomised trial.
    Autorzy:
    Kirwan P; Department of Zoology, University of Dublin, Trinity College, Dublin 2, Ireland. />Asaolu SO
    Molloy SF
    Abiona TC
    Jackson AL
    Holland CV
    Pokaż więcej
    Źródło:
    BMC infectious diseases [BMC Infect Dis] 2009 Feb 19; Vol. 9, pp. 20. Date of Electronic Publication: 2009 Feb 19.
    Typ publikacji:
    Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Urban Population*
    Albendazole/*therapeutic use
    Helminthiasis/*drug therapy
    Helminths/*physiology
    Soil/*parasitology
    Albendazole/administration & dosage ; Animals ; Child, Preschool ; Female ; Helminthiasis/epidemiology ; Humans ; Infant ; Linear Models ; Male ; Nigeria ; Time Factors
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-12 z 12

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies